Full View

Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

L Vines, D Sotelo, A Johnson, E Dennis… - Intelligent …, 2022 - mednexus.org
Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, has been
exclusively used as an anesthetic in medicine and has led to new insights into the …
被引用次数：10 相关文章
[HTML] sciencedirect.com

[HTML][HTML] Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

L Vines, D Sotelo, A Johnson, E Dennis, P Manza… - Intelligent …, 2022 - Elsevier
Ketamine, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist, has been
exclusively used as an anesthetic in medicine and has led to new insights into the …

Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions.

L Vines, D Sotelo, A Johnson, E Dennis… - Intelligent …, 2022 - europepmc.org
Ketamine, a noncompetitive NMDA receptor antagonist, has been exclusively used as an
anesthetic in medicine and has led to new insights into the pathophysiology of …

Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

L Vines, D Sotelo, A Johnson, E Dennis… - Intelligent …, 2022 - pubmed.ncbi.nlm.nih.gov
Ketamine, a noncompetitive NMDA receptor antagonist, has been exclusively used as an
anesthetic in medicine and has led to new insights into the pathophysiology of …
[HTML] nih.gov

[HTML][HTML] Ketamine use disorder: preclinical, clinical, and neuroimaging evidence to support proposed mechanisms of actions

L Vines, D Sotelo, A Johnson, E Dennis… - Intelligent …, 2022 - ncbi.nlm.nih.gov
Ketamine, a noncompetitive NMDA receptor antagonist, has been exclusively used as an
anesthetic in medicine and has led to new insights into the pathophysiology of …